Skip to main content
. 2022 Oct 8;270(2):1162–1177. doi: 10.1007/s00415-022-11388-1
(1) Indicative Is the physiomarker sufficiently linked to the severity of fluctuating symptoms?
(2) Individual Is the physiomarker detectable in every patient and patient-specific if needed?
(3) Implementable Is the physiomarker (technically) capable of automatically titrating stimulation?